VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE

The present disclosure relates to the c-Abl inhibitor vodobatinib, or a pharmaceutically acceptable salt thereof, for use in treating, delaying, inhibiting, or suppressing the progression of neurodegenerative diseases, preferably early stage Parkinson's disease, in a subject. La présente invent...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOLDFINE, Andrew, YAO, Siu-Long, TALLURI, Ravi Sankar Prasad, DAMLE, Nitin Krishnaji, MANDHANE, Sanjay Nandlalji, RAMANATHAN, Vikram Krishna, FAULKNER, Robert D
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to the c-Abl inhibitor vodobatinib, or a pharmaceutically acceptable salt thereof, for use in treating, delaying, inhibiting, or suppressing the progression of neurodegenerative diseases, preferably early stage Parkinson's disease, in a subject. La présente invention concerne l'inhibiteur de c-Abl vodobatinib, ou un sel pharmaceutiquement acceptable de celui-ci, destiné à être utilisé pour traiter, retarder, inhiber ou empêcher la progression de maladies neurodégénératives, de préférence de la maladie de Parkinson au stade précoce, chez un sujet.